WHO ICTRP trial
A 12 week, double-blind, randomized, placebo-controlled clinical trial for the…
KCT0001542 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0001542 |
|---|---|
| Public title | A 12 week, double-blind, randomized, placebo-controlled clinical trial for the evaluation of the efficacy and safety of green coffee bean extract(GCB50) on reducing body weight and body fat of overweight subjects |
| Scientific title | A 12 week, double-blind, randomized, placebo-controlled clinical trial for the evaluation of the efficacy and safety of green coffee bean extract(GCB50) on reducing body weight and body fat of overweight subjects |
| Primary sponsor | Dong Il Pharmtek |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Endocrine, nutritional and metabolic disease |
| Interventions | Dietary Supplement : Subjects will be randomized to receive GCB50 (Eclonia cava enzymatic extracts) 4mg or placebo. Subjects will orally self-adminster Eclonia cava enzymatic extracts or placebo bid, 2 capsules twice per day for 12weeks. |
| Registration date | Jun 29, 2015 |
| Target size | 80 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: